For decades, the "central dogma" of molecular biology focused on how DNA is transcribed into messenger RNA (mRNA), which is then translated into protein. Any RNA that didn't code for a protein was often dismissed as "genomic junk." However, as Min Fu and colleagues note in Long noncoding RNAs in digestive system cancers, these non-coding transcripts are actually master regulators.
The most pervasive mechanism for this regulation is the Competing Endogenous RNA (ceRNA) hypothesis. This framework describes a hidden economy of molecular competition where different RNA species—long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and even pseudogenes—act as "molecular sponges" to control gene expression.
The Molecular Sponge Mechanism
To understand how a ceRNA network works, we must first look at the role of microRNAs (miRNAs). Normally, miRNAs act as silencers: they bind to specific target mRNAs and either trigger their degradation or block their translation into proteins. This is a primary "brake" on gene expression.
The ceRNA mechanism introduces a decoy. As explained by Yuyou Yang in Effect Of XBP1 Deficiency In Cartilage On The Regulatory Network Of LncRNA/circRNA-miRNA-mRNA, non-coding RNAs can possess the same binding sites as the target mRNA. When these non-coding "sponges" are highly expressed, they sequester (or "soak up") the miRNAs.
By tying up the miRNAs, the sponges prevent them from reaching their intended mRNA targets. This effectively "releases the brakes," allowing the mRNA to be translated into protein. In this way, an lncRNA can indirectly upregulate a protein without ever coding for it.
Competition as a Regulatory Circuit
This interaction is rarely a simple one-to-one relationship. Instead, it forms a complex network or "circuit." Researchers like Wanqing Weng use multi-database integration to map these interactions, as seen in their work on pancreatic adenocarcinoma.
The intuition here is that the cell maintains a shared pool of miRNAs. Any transcript with a matching binding site—whether it's an lncRNA, a circRNA, or a pseudogene—competes for a piece of that pool. Hui Wang demonstrates that even pseudogenes (evolutionary "echoes" of genes) participate in this competition, regulating their protein-coding cousins by acting as decoys.
Clinical Implications of Dysregulated Sponging
When these networks are balanced, they maintain cellular homeostasis. When they break, they drive disease.
In cancer, oncogenic lncRNAs often act as sponges for tumor-suppressive miRNAs. For instance, Lu Yan found that the lncRNA SNHG5 promotes melanoma by sponging miR-155 SNHG5 promotes proliferation and induces apoptosis in melanoma by sponging miR-155. Similarly, Bing Liu mapped a "relay race" in colorectal cancer where LINC01296 sponges miR-26a, eventually triggering the PI3K/AKT signaling pathway.
This mechanism isn't limited to cancer. It plays a role in:
- Neurodegeneration: Paulami Chatterjee identified ceRNA loops that modulate genes involved in Parkinson’s Disease Biological networks in Parkinson’s disease.
- Tissue Repair: Jia Wang showed how the lncRNA HCG18 acts as a sponge to regulate blood vessel growth after a stroke Construction of a Competitive Endogenous RNA Network Associated with Angiogenesis in Ischemic Stroke.
- Bone Health: Ke Wang identified the lncRNA OGRU, which sponges inhibitory miRNAs to boost bone-forming proteins Bone-targeted lncRNA OGRU alleviates unloading-induced bone loss.
Identifying Master Regulators
Because these networks are so complex, researchers use bioinformatics to identify "hubs"—specific RNAs that exert outsized influence on the network. Xiaonan Fang and colleagues constructed a comprehensive map for head and neck squamous cell carcinoma, identifying a circuit of 8 miRNAs and 71 lncRNAs that dictate patient survival.
By understanding these competitive axes—such as the PVT1/miR-128-3p/GREM1 axis identified by Chao Fu in glioma—scientists can move beyond looking at single genes. They can instead target the "sponges" themselves, using them as biomarkers for diagnosis or as "druggable" targets to restore the cell's natural regulatory balance.